215 related articles for article (PubMed ID: 16755566)
21. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Kharchenko VP; Datsenko PV; Panyshin GA; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):531-7. PubMed ID: 17168361
[TBL] [Abstract][Full Text] [Related]
22. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
23. Paediatric Hodgkin lymphoma with Reed-Sternberg and mononuclear Hodgkin cells in the bone marrow aspirate.
Swart L; Shuttleworth MH; Opie JJ; van Schalkwyk WA
Br J Haematol; 2012 Apr; 157(1):2. PubMed ID: 22329501
[No Abstract] [Full Text] [Related]
24. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
25. [Hodgkin's disease in pregnancy--case report and literature review].
Schäffer M; Hegenbart U; Klostermann K; Stepan H
Z Geburtshilfe Neonatol; 2003; 207(2):71-3. PubMed ID: 12740750
[TBL] [Abstract][Full Text] [Related]
26. Osseous presentation of Hodgkin's disease: a case report and review of the literature.
Köseoğlu RD; Senayli A; Biçakçi U; Onuk-Filiz N; Sezer T; Celkan T
Turk J Pediatr; 2007; 49(2):218-22. PubMed ID: 17907527
[TBL] [Abstract][Full Text] [Related]
27. [Primary multifocal osseous Hodgkin lymphoma].
Oshikawa G; Arai A; Sasaki K; Ichinohasama R; Miura O
Rinsho Ketsueki; 2009 Feb; 50(2):92-6. PubMed ID: 19265301
[TBL] [Abstract][Full Text] [Related]
28. Stanford V and radiotherapy for Hodgkin's disease.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):413. PubMed ID: 12162915
[No Abstract] [Full Text] [Related]
29. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
30. Unusual presentation of Hodgkin's lymphoma.
Knibbeler-van Rossum CT; Peters FJ; Erdkamp FL; Bos LP
Ann Oncol; 2002 Apr; 13(4):637-8. PubMed ID: 12056718
[No Abstract] [Full Text] [Related]
31. Hodgkin's lymphoma: better outcomes with fewer drugs?
Casasnovas O; Coiffier B
Lancet; 2015 Apr; 385(9976):1371-3. PubMed ID: 25539731
[No Abstract] [Full Text] [Related]
32. [Spinal involvement as first presentation of Hodgkin's disease].
Navarro Calzada J; Cuesta Muñoz J; Crusells Canales MJ; Letona Carbajo S; Sanjoaquín Conde I; Amiguet García JA
An Med Interna; 2006 Mar; 23(3):142-3. PubMed ID: 16737439
[No Abstract] [Full Text] [Related]
33. Presentation of Hodgkin's lymphoma with Ophelia syndrome.
Olmos D; Rueda A; Jurado JM; Alba E
J Clin Oncol; 2007 May; 25(13):1802-3. PubMed ID: 17470872
[No Abstract] [Full Text] [Related]
34. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's disease. Treatment of resistant patients.
De Lena M; Santoro A
Cancer Clin Trials; 1979; 2(1):83-5. PubMed ID: 93032
[No Abstract] [Full Text] [Related]
36. [Is the ABVD an optimal regimen for Hodgkins disease?].
Nakamura S
Rinsho Ketsueki; 1998 Feb; 39(2):109-10. PubMed ID: 9545813
[No Abstract] [Full Text] [Related]
37. The vanishing bile duct syndrome in a child with Hodgkin disease.
Ozkan A; Yoruk A; Celkan T; Apak H; Yildiz I; Ozbay G
Med Pediatr Oncol; 2001 Mar; 36(3):398-9. PubMed ID: 11241447
[No Abstract] [Full Text] [Related]
38. Prognostic factors in early-stage Hodgkin's disease.
Sarris AH
J Clin Oncol; 1997 Jan; 15(1):411-2. PubMed ID: 8996173
[No Abstract] [Full Text] [Related]
39. [Primary pulmonary Hodgkin's disease].
Hosoi K; Chikuie N; Min KY; Satoh T; Tokumine Y; Ishikawa K; Maeda H; Ueda K; Inoue M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1399-401. PubMed ID: 16097597
[No Abstract] [Full Text] [Related]
40. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
